Analyze Diet
Clinical and vaccine immunology : CVI2011; 18(9); 1562-1567; doi: 10.1128/CVI.05123-11

Antibody profiling of Borrelia burgdorferi infection in horses.

Abstract: Infection with Borrelia burgdorferi is common in horses and ponies from the New England and mid-Atlantic regions of the United States. Here, we evaluated luciferase immunoprecipitation systems (LIPS) for profiling antibody responses against three different antigenic targets for the diagnosis of equine B. burgdorferi infection. LIPS testing of horse serum samples suspected of Lyme infection revealed that approximately 75% of the horse samples (114/159) were seropositive against the synthetic VOVO antigen, comprising repeated immunodominant C6 epitopes as well as OspC immunodominant epitopes. A comparison of VOVO and immunofluorescence assays (IFA) showed that 51% of the samples were positive in both assays (VOVO(+)/IFA(+)), 13% were VOVO(-)/IFA(+), 21% were VOVO(+)/IFA(-), and 15% were negative in both. To further understand humoral responses to B. burgdorferi and reconcile the diagnostic differences between IFA and VOVO, two additional B. burgdorferi LIPS tests were performed with DbpA and DbpB. Robust seropositive antibody responses against DbpA and/or DbpB were detected in 98% (79/81) of the VOVO(+)/IFA(+) and 93% (50/54) of the discrepant samples. Additionally, some of the samples negative by both VOVO and IFA showed immunoreactivity against DbpA and/or DbpB. Overall, 94% of the suspected horse samples were seropositive by LIPS, and heat map analysis revealed that seropositive samples often were immunoreactive with at least two of the three antigens. These results suggest that LIPS tests employing multiple recombinant antigens offer a promising approach for the evaluation of antibody responses in Lyme disease.
Publication Date: 2011-07-20 PubMed ID: 21775514PubMed Central: PMC3165210DOI: 10.1128/CVI.05123-11Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • N.I.H.
  • Extramural

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research investigates the application of luciferase immunoprecipitation systems (LIPS) for determining the presence of Borrelia burgdorferi infection, a common bacterial infection, in horses. This was conducted by profiling the horses’ antibody responses to certain antigen targets. The study indicated a high success rate for LIPS tests, suggesting them as an effective method for diagnosing this infection in horses.

Experiment and Findings

The researchers used LIPS test to evaluate the antibody response of horse serum samples suspected of having Lyme disease against three different antigenic targets. The primary findings from the experiment are as follows:

  • About 75% of the horse serum samples were seropositive against the synthetic VOVO antigen, indicating the presence of the B. burgdorferi infection.
  • Further comparison using VOVO and immunofluorescence assays (IFA) revealed discrepancies in the results. About 51% of the samples were positive in both assays (VOVO(+)/IFA(+)), while the rest demonstrated mixed results.
  • Two additional B. burgdorferi LIPS tests were performed using DbpA and DbpB to reconcile these discrepancies and better understand the humoral responses to B. burgdorferi. Robust seropositive antibody responses were detected against DbpA and/or DbpB in the majority of the VOVO(+)/IFA(+) and discrepant samples.
  • Overall, 94% of the suspected horse serum samples were seropositive by LIPS and often showed immunoreactivity with at least two of the three antigens.

Interpretation and Potential Implications

The study results reveal the efficacy of LIPS in diagnosing B. burgdorferi infection in horses. This is significant as it provides an effective means of identifying the infection, particularly in regions where this disease is prevalent.

  • The combined use of the VOVO antigen and the immunofluorescence assays (IFA) successfully diagnosed the infection in 51% of the cases, indicating a promising approach to resolving the discrepancies in the diagnosis of the disease.
  • The additional LIPS tests with DbpA and DbpB detected antibody responses against these antibodies, potentially improving the diagnosis and management of B. burgdorferi infection.
  • A notable aspect is the prevalence of seropositive results by LIPS, which suggests that this approach can be widely implemented as a diagnostic tool for Lyme disease.

In conclusion, the research suggests that the LIPS tests offer a promising approach in the evaluation of antibody responses for Lyme disease diagnosis, providing a potential leap in effectively managing Lyme disease in horses.

Cite This Article

APA
Burbelo PD, Bren KE, Ching KH, Coleman A, Yang X, Kariu T, Iadarola MJ, Pal U. (2011). Antibody profiling of Borrelia burgdorferi infection in horses. Clin Vaccine Immunol, 18(9), 1562-1567. https://doi.org/10.1128/CVI.05123-11

Publication

ISSN: 1556-679X
NlmUniqueID: 101252125
Country: United States
Language: English
Volume: 18
Issue: 9
Pages: 1562-1567

Researcher Affiliations

Burbelo, Peter D
  • National Institutes of Health, Bethesda, MD 20892, USA. burbelop@nidcr.nih.gov
Bren, Kathleen E
    Ching, Kathryn H
      Coleman, Adam
        Yang, Xiuli
          Kariu, Toru
            Iadarola, Michael J
              Pal, Utpal

                MeSH Terms

                • Adhesins, Bacterial / genetics
                • Adhesins, Bacterial / immunology
                • Adhesins, Bacterial / metabolism
                • Animals
                • Antibodies, Bacterial / blood
                • Antigens, Bacterial / genetics
                • Antigens, Bacterial / immunology
                • Antigens, Bacterial / metabolism
                • Bacterial Proteins / genetics
                • Bacterial Proteins / immunology
                • Bacterial Proteins / metabolism
                • Borrelia burgdorferi / genetics
                • Borrelia burgdorferi / immunology
                • Fluorescent Antibody Technique
                • Horse Diseases / diagnosis
                • Horse Diseases / immunology
                • Horse Diseases / microbiology
                • Horses
                • Immunoprecipitation
                • Luciferases / genetics
                • Luciferases / metabolism
                • Lyme Disease / diagnosis
                • Lyme Disease / veterinary
                • Recombinant Proteins / genetics
                • Recombinant Proteins / immunology

                Grant Funding

                • AR055323 / NIAMS NIH HHS
                • R01 AI080615 / NIAID NIH HHS
                • AI080615 / NIAID NIH HHS
                • R56 AI080615 / NIAID NIH HHS
                • R03 AR055323 / NIAMS NIH HHS

                References

                This article includes 33 references
                1. Bacon RM, Biggerstaff BJ, Schriefer ME, Gilmore RD Jr, Philipp MT, Steere AC, Wormser GP, Marques AR, Johnson BJ. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates.. J Infect Dis 2003 Apr 15;187(8):1187-99.
                  pmc: PMC7109709pubmed: 12695997doi: 10.1086/374395google scholar: lookup
                2. Barbour AG, Jasinskas A, Kayala MA, Davies DH, Steere AC, Baldi P, Felgner PL. A genome-wide proteome array reveals a limited set of immunogens in natural infections of humans and white-footed mice with Borrelia burgdorferi.. Infect Immun 2008 Aug;76(8):3374-89.
                  pmc: PMC2493225pubmed: 18474646doi: 10.1128/IAI.00048-08google scholar: lookup
                3. Berrada ZL, Telford SR 3rd. Burden of tick-borne infections on American companion animals.. Top Companion Anim Med 2009 Nov;24(4):175-81.
                  pmc: PMC2802828pubmed: 19945085doi: 10.1053/j.tcam.2009.06.005google scholar: lookup
                4. Branda JA, Aguero-Rosenfeld ME, Ferraro MJ, Johnson BJ, Wormser GP, Steere AC. 2-tiered antibody testing for early and late Lyme disease using only an immunoglobulin G blot with the addition of a VlsE band as the second-tier test.. Clin Infect Dis 2010 Jan 1;50(1):20-6.
                  pubmed: 19947857doi: 10.1086/648674google scholar: lookup
                5. Burbelo PD, Ching KH, Bren KE, Iadarola MJ. Searching for biomarkers: humoral response profiling with luciferase immunoprecipitation systems.. Expert Rev Proteomics 2011 Jun;8(3):309-16.
                  pmc: PMC3818131pubmed: 21679112doi: 10.1586/epr.11.23google scholar: lookup
                6. Burbelo PD, Ching KH, Bush ER, Han BL, Iadarola MJ. Antibody-profiling technologies for studying humoral responses to infectious agents.. Expert Rev Vaccines 2010 Jun;9(6):567-78.
                  pmc: PMC3417761pubmed: 20518713doi: 10.1586/erv.10.50google scholar: lookup
                7. Burbelo PD, Ching KH, Esper F, Iadarola MJ, Delwart E, Lipkin WI, Kapoor A. Serological studies confirm the novel astrovirus HMOAstV-C as a highly prevalent human infectious agent.. PLoS One 2011;6(8):e22576.
                8. Burbelo PD, Ching KH, Klimavicz CM, Iadarola MJ. Antibody profiling by Luciferase Immunoprecipitation Systems (LIPS).. J Vis Exp 2009 Oct 7;(32).
                  pmc: PMC3164068pubmed: 19812534doi: 10.3791/1549google scholar: lookup
                9. Burbelo PD, Ching KH, Mattson TL, Light JS, Bishop LR, Kovacs JA. Rapid antibody quantification and generation of whole proteome antibody response profiles using LIPS (luciferase immunoprecipitation systems).. Biochem Biophys Res Commun 2007 Jan 26;352(4):889-95.
                  pubmed: 17157815doi: 10.1016/j.bbrc.2006.11.140google scholar: lookup
                10. Burbelo PD, Issa AT, Ching KH, Cohen JI, Iadarola MJ, Marques A. Rapid, simple, quantitative, and highly sensitive antibody detection for lyme disease.. Clin Vaccine Immunol 2010 Jun;17(6):904-9.
                  pmc: PMC2884422pubmed: 20392886doi: 10.1128/CVI.00476-09google scholar: lookup
                11. Burbelo PD, Issa AT, Ching KH, Exner M, Drew WL, Alter HJ, Iadarola MJ. Highly quantitative serological detection of anti-cytomegalovirus (CMV) antibodies.. Virol J 2009 May 1;6:45.
                  pmc: PMC2683803pubmed: 19409090doi: 10.1186/1743-422X-6-45google scholar: lookup
                12. Burbelo PD, Issa AT, Ching KH, Wyvill KM, Little RF, Iadarola MJ, Kovacs JA, Yarchoan R. Distinct profiles of antibodies to Kaposi sarcoma-associated herpesvirus antigens in patients with Kaposi sarcoma, multicentric Castleman disease, and primary effusion lymphoma.. J Infect Dis 2010 Jun 15;201(12):1919-22.
                  pmc: PMC2873114pubmed: 20443737doi: 10.1086/652869google scholar: lookup
                13. Burbelo PD, Leahy HP, Groot S, Bishop LR, Miley W, Iadarola MJ, Whitby D, Kovacs JA. Four-antigen mixture containing v-cyclin for serological screening of human herpesvirus 8 infection.. Clin Vaccine Immunol 2009 May;16(5):621-7.
                  pmc: PMC2681582pubmed: 19261774doi: 10.1128/CVI.00474-08google scholar: lookup
                14. Burbelo PD, Leahy HP, Iadarola MJ, Nutman TB. A four-antigen mixture for rapid assessment of Onchocerca volvulus infection.. PLoS Negl Trop Dis 2009;3(5):e438.
                15. Burbelo PD, Meoli E, Leahy HP, Graham J, Yao K, Oh U, Janik JE, Mahieux R, Kashanchi F, Iadarola MJ, Jacobson S. Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).. Retrovirology 2008 Oct 20;5:96.
                  pmc: PMC2580768pubmed: 18937847doi: 10.1186/1742-4690-5-96google scholar: lookup
                16. Butler CM, Houwers DJ, Jongejan F, van der Kolk JH. Borrelia burgdorferi infections with special reference to horses. A review.. Vet Q 2005 Dec;27(4):146-56.
                  pubmed: 16402512
                17. Cinco M, Ruscio M, Rapagna F. Evidence of Dbps (decorin binding proteins) among European strains of Borrelia burgdorferi sensu lato and in the immune response of LB patient sera.. FEMS Microbiol Lett 2000 Feb 1;183(1):111-4.
                18. Coleman AS, Pal U. BBK07, a dominant in vivo antigen of Borrelia burgdorferi, is a potential marker for serodiagnosis of Lyme disease.. Clin Vaccine Immunol 2009 Nov;16(11):1569-75.
                  pmc: PMC2772389pubmed: 19776192doi: 10.1128/CVI.00301-09google scholar: lookup
                19. Coleman AS, Rossmann E, Yang X, Song H, Lamichhane CM, Iyer R, Schwartz I, Pal U. BBK07 immunodominant peptides as serodiagnostic markers of Lyme disease.. Clin Vaccine Immunol 2011 Mar;18(3):406-13.
                  pmc: PMC3067378pubmed: 21177911doi: 10.1128/CVI.00461-10google scholar: lookup
                20. Embers ME, Jacobs MB, Johnson BJ, Philipp MT. Dominant epitopes of the C6 diagnostic peptide of Borrelia burgdorferi are largely inaccessible to antibody on the parent VlsE molecule.. Clin Vaccine Immunol 2007 Aug;14(8):931-6.
                  pmc: PMC2044495pubmed: 17567769doi: 10.1128/CVI.00075-07google scholar: lookup
                21. Fikrig E, Huguenel ED, Berland R, Rahn DW, Hardin JA, Flavell RA. Serologic diagnosis of Lyme disease using recombinant outer surface proteins A and B and flagellin.. J Infect Dis 1992 Jun;165(6):1127-32.
                  pubmed: 1583333doi: 10.1093/infdis/165.6.1127google scholar: lookup
                22. Gomes-Solecki MJ, Dunn JJ, Luft BJ, Castillo J, Dykhuizen DE, Yang X, Glass JD, Dattwyler RJ. Recombinant chimeric Borrelia proteins for diagnosis of Lyme disease.. J Clin Microbiol 2000 Jul;38(7):2530-5.
                23. Hansen MG, Christoffersen M, Thuesen LR, Petersen MR, Bojesen AM. Seroprevalence of Borrelia burgdorferi sensu lato and Anaplasma phagocytophilum in Danish horses.. Acta Vet Scand 2010 Jan 18;52(1):3.
                  pmc: PMC2818635pubmed: 20082693doi: 10.1186/1751-0147-52-3google scholar: lookup
                24. Heikkilä T, Seppälä I, Saxen H, Panelius J, Yrjänäinen H, Lahdenne P. Species-specific serodiagnosis of Lyme arthritis and neuroborreliosis due to Borrelia burgdorferi sensu stricto, B. afzelii, and B. garinii by using decorin binding protein A.. J Clin Microbiol 2002 Feb;40(2):453-60.
                25. Imai DM, Barr BC, Daft B, Bertone JJ, Feng S, Hodzic E, Johnston JM, Olsen KJ, Barthold SW. Lyme neuroborreliosis in 2 horses.. Vet Pathol 2011 Nov;48(6):1151-7.
                  doi: 10.1177/0300985811398246pubmed: 21285382google scholar: lookup
                26. Johnson AL, Divers TJ, Chang YF. Validation of an in-clinic enzyme-linked immunosorbent assay kit for diagnosis of Borrelia burgdorferi infection in horses.. J Vet Diagn Invest 2008 May;20(3):321-4.
                  pubmed: 18460618doi: 10.1177/104063870802000309google scholar: lookup
                27. Liang FT, Steere AC, Marques AR, Johnson BJ, Miller JN, Philipp MT. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE.. J Clin Microbiol 1999 Dec;37(12):3990-6.
                28. Magnarelli LA, Ijdo JW, Padula SJ, Flavell RA, Fikrig E. Serologic diagnosis of Lyme borreliosis by using enzyme-linked immunosorbent assays with recombinant antigens.. J Clin Microbiol 2000 May;38(5):1735-9.
                29. Marques AR. Lyme disease: a review.. Curr Allergy Asthma Rep 2010 Jan;10(1):13-20.
                  pubmed: 20425509doi: 10.1007/s11882-009-0077-3google scholar: lookup
                30. Morshed MG, Scott JD, Fernando K, Geddes G, McNabb A, Mak S, Durden LA. Distribution and characterization of Borrelia burgdorferi isolates from Ixodes scapularis and presence in mammalian hosts in Ontario, Canada.. J Med Entomol 2006 Jul;43(4):762-73.
                31. Panelius J, Lahdenne P, Saxén H, Carlsson SA, Heikkilä T, Peltomaa M, Lauhio A, Seppälä I. Diagnosis of Lyme neuroborreliosis with antibodies to recombinant proteins DbpA, BBK32, and OspC, and VlsE IR6 peptide.. J Neurol 2003 Nov;250(11):1318-27.
                  pubmed: 14648148doi: 10.1007/s00415-003-0205-2google scholar: lookup
                32. Panelius J, Sillanpää H, Seppälä I, Sarvas H, Lahdenne P. Antibodies to recombinant decorin-binding proteins A and B in the cerebrospinal fluid of patients with Lyme neuroborreliosis.. Scand J Infect Dis 2007;39(9):775-80.
                  pubmed: 17701715doi: 10.1080/00365540701367744google scholar: lookup
                33. Philipp MT, Wormser GP, Marques AR, Bittker S, Martin DS, Nowakowski J, Dally LG. A decline in C6 antibody titer occurs in successfully treated patients with culture-confirmed early localized or early disseminated Lyme Borreliosis.. Clin Diagn Lab Immunol 2005 Sep;12(9):1069-74.

                Citations

                This article has been cited 6 times.
                1. Kašpárková N, Bártová E, Žákovská A, Budíková M, Sedlák K. Antibodies against Borrelia burgdorferi Sensu Lato in Clinically Healthy and Sick Horses: First Report from the Czech Republic. Microorganisms 2023 Jun 29;11(7).
                2. Chen S, Xu M, Wu X, Bai Y, Shi J, Zhou M, Wu Q, Tang S, Deng F, Qin B, Shen S. A new luciferase immunoprecipitation system assay provided serological evidence for missed diagnosis of severe fever with thrombocytopenia syndrome. Virol Sin 2022 Feb;37(1):107-114.
                  doi: 10.1016/j.virs.2022.01.018pubmed: 35234635google scholar: lookup
                3. Campos JBV, Martins FS, de Oliveira CE, Taveira AA, Oliveira JR, Gonçalves LR, Cordeiro MD, Calchi AC, de Campos Binder L, Serpa MCA, Barbieri ARM, Labruna MB, Machado RZ, de Andrade GB, André MR, Herrera HM. Tick-borne zoonotic agents infecting horses from an urban area in Midwestern Brazil: epidemiological and hematological features. Trop Anim Health Prod 2021 Sep 22;53(5):475.
                  doi: 10.1007/s11250-021-02887-wpubmed: 34553290google scholar: lookup
                4. Divers TJ, Gardner RB, Madigan JE, Witonsky SG, Bertone JJ, Swinebroad EL, Schutzer SE, Johnson AL. Borrelia burgdorferi Infection and Lyme Disease in North American Horses: A Consensus Statement. J Vet Intern Med 2018 Mar;32(2):617-632.
                  doi: 10.1111/jvim.15042pubmed: 29469222google scholar: lookup
                5. Caol S, Divers T, Crisman M, Chang YF. In vitro susceptibility of Borrelia burgdorferi isolates to three antibiotics commonly used for treating equine Lyme disease. BMC Vet Res 2017 Sep 29;13(1):293.
                  doi: 10.1186/s12917-017-1212-3pubmed: 28962614google scholar: lookup
                6. Lee SH, Yun SH, Choi E, Park YS, Lee SE, Cho GJ, Kwon OD, Kwak D. Serological Detection of Borrelia burgdorferi among Horses in Korea. Korean J Parasitol 2016 Feb;54(1):97-101.
                  doi: 10.3347/kjp.2016.54.1.97pubmed: 26951987google scholar: lookup